[1] 蒋卫民,潘孝彰,康来仪,等. 上海地区成人不同年龄组间CD4、CD8 淋巴细胞计数正常值调查[J] .中华传染病杂志,2002,20(4):203-205. [2] 林 琳,苏生到,傅继华,等. 山东省健康成年人T淋巴细胞亚群正常参考值范围[J] .中华预防医学杂志,2009,43(11):1040-1041. [3] 徐 红,毛一香,张学光,等.晚期消化道肿瘤患者化疗前后T细胞亚群的变化[J] .癌症, 2008, 27(4):418-424. [4] Kayser G, Schulte-Uentrop L, Sienel W, et al. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas[J] . Lung cancer, 2012, 76(3):445-451. [5] 马新华.调节性T细胞与肿瘤研究进展[J] .国际妇产科学杂志, 2011, 38(2): 112-114. [6] Karagz B, Bilgi O, Gümüs M,et al.CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients[J] .Med Oncol, 2010, 27(1):29-33. [7] Jentsch-Ullrich K, Koenigsmann M,Mohren M, et al. Lymphocyte subsets′ reference ranges in an age- and gender-balanced population of 100 healthy adults-a monocentric German study[J] .Clin Immunol, 2005, 116(2):192-197. [8] Kaaba SA, Al Fadhli S, Khamis A. Reference values of lymphocyte subsets in the normal healthy adult Kuwaiti Arab population[J] . Immunol Lett, 2002, 81(3): 199-203. [9] 郭志宏,姚亚萍,李西婷,等. 浙江地区健康青少年和成人外周血 T 淋巴细胞免疫表型调查及正常参考值范围的建立[J] .中国预防医学杂志, 2008, 9(1): 32-35. [10] Lydyard PM, Whelan A, Fanger MW. 免疫学[M] . 林慰慈,译. 北京:科学出版社,2010:34-35. [11] Hsu HC, Scott DK, Zhang P. CD8 T-cell immune phenotype of successful aging[J] .Mech Ageing Dev, 2006, 127(3):231-239. [12] Capri M, Monti D, Salvioli S, et al. Complexity of anti-immunosenescence strategies in humans[J] . Artif Organs,2006,30(10):730-742.[13] Son NH, Murray S, Yanovski J, et al. Lineage-specific telomere short ending and unaltered capacity for telomerase expression in human T an d B lymphocytes with age[J] . J Immunol, 2000, 165(3): 1191-1196. [14] Rossi RL, Rossetti G, Wenandy L, et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b[J] . Nat Immunol, 2011, 12(8):796-803. [15] Liu W, Putnan AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells[J] . J Exp Med, 2006, 203(7):1701-1711. [16] Hong H, Gu Y, Zhang H, et al. Depletion of CD4+CD25+ regulatory T cells enhances natural killer T cell-mediated anti-tumour immunity in a murine mammary breast cancer model[J] . Clin Exp Immunol, 2010, 159(1):93-99. [17] Ghiringhelli F, Menard C, Puig PE, et al. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients[J] .Cancer Immunol Immunother, 2007, 56(5):641-648. |